Allan Collins
Chief Tech/Sci/R&D Officer at NXSTAGE MEDICAL, INC.
Net worth: 39 888 $ as of 31/03/2024
Profile
Allan J.
Collins is currently the Director at SeaStar Medical, Inc., the Independent Director at Seastar Medical Holding Corp., and the Chief Medical Officer at NxStage Medical, Inc. He previously served as the President at Advances In Kidney Disease & Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/04/2024 | 54,343 ( 0.08% ) | 39 888 $ | 31/03/2024 |
Allan Collins active positions
| Companies | Position | Start |
|---|---|---|
| NXSTAGE MEDICAL, INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| SEASTAR MEDICAL HOLDING CORPORATION | Director/Board Member | 01/01/2021 |
SeaStar Medical, Inc.
 SeaStar Medical, Inc. Information Technology ServicesTechnology Services Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO. | Director/Board Member | 08/01/2021 |
Former positions of Allan Collins
| Companies | Position | End |
|---|---|---|
Advances In Kidney Disease & Health
 Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | President | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SEASTAR MEDICAL HOLDING CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
SeaStar Medical, Inc.
SeaStar Medical, Inc. Information Technology ServicesTechnology Services Seastar Medical, Inc. manufactures and supplies medical devices. It offers medical device that cures inflammation-based diseases and conditions. The company was founded by James P. Sherblom in July 2007 and is headquartered in Denver, CO. | Technology Services |
NxStage Medical, Inc.
 NxStage Medical, Inc. Medical SpecialtiesHealth Technology NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers and needles for apheresis. The Services segment includes revenues from dialysis services provided to patients at its recently opened NxStage Kidney Care dialysis centers. The company was founded by Jeffrey H. Burbank in December 1998 and is headquartered in Waltham, MA. | Health Technology |
Advances In Kidney Disease & Health
Advances In Kidney Disease & Health Miscellaneous Commercial ServicesCommercial Services Advances In Kidney Disease & Health provides awareness on kidney and urinary tract diseases. The organization helps to increase the availability of all organs for transplantation. The company was founded in 1950 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Allan Collins